FHI vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 16, 2026

FHI

58.6
AI Score
VS
CNS Wins

CNS

62.0
AI Score

Investment Advisor Scores

FHI

59score
Recommendation
HOLD

CNS

62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI CNS Winner
Forward P/E 11.3507 23.1481 FHI
PEG Ratio 2.3173 1.9122 CNS
Revenue Growth 13.1% 8.3% FHI
Earnings Growth 1.6% 6.5% CNS
Tradestie Score 58.6/100 62.0/100 CNS
Profit Margin 21.5% 27.5% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CNS

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.